| Home | Generics | Biosimilars | Docs & Positions | Facts & Figures | Press Room | Conferences | Links |
Making Medicines affordable.News RoomLatest NewsPress ReleasesReleases 2007 Releases 2006 Releases 2005 Releases 2004 Releases 2003Media KitGenerics Industry |
EGA Press ReleaseFriday, 14 May 2004Rory O'Riordan and EGA are delighted to receive the first “Business Humanitarian Award” as announced in the following BHF Press Release.
PRESS RELEASE First Business Humanitarian Award Presented to Pharmaceutical Association by the Business Humanitarian Forum GENEVA—14 May 2004. Celebrating its five-year anniversary, the Business Humanitarian Forum presented its first Business Humanitarian Award to Rory O’Riordan, President of the European Generic medicines Association (EGA). The Business Humanitarian Award honors business leaders from the private sector who engage in specific economic and social development programs that help alleviate the world’s most pressing humanitarian problems. Under Mr. O’Riordan’s leadership, the EGA is contributing to poverty alleviation in Afghanistan by helping to build a locally owned generic medicines factory in Kabul. The EGA is donating production equipment, free training, free business plans and quality control tools, and will monitor the plant over a one year period to ensure sustainable production levels.* The Afghan Ministry of Health has welcomed this project and has asked the EGA and the BHF to help build such factories in other Afghan cities, to meet the country’s high demand for essential medicines. The medicines plant is the pilot project of a larger public-private partnership program that is carried out jointly by the Business Humanitarian Forum, local investors, UN agencies and business partners. The program seeks to rehabilitate the country’s economic infrastructure with the support of the private sector. The medicines plant represents a first step in a series of sustainable economic development projects that will provide a visible reason for hope for the future. Afghanistan is one of the poorest countries in the world and currently has little productive capacity for basic goods. Many basic needs are met through imports. The infant mortality rate is among the highest in the world, with many deaths resulting from basic infectious diseases due to a lack of access to essential medicines. Local production of quality medicines will help reduce the infant mortality rate and will provide employment and training opportunities at the factories. * In 2002, the EGA launched a corporate social responsibility program called Access to Medicines. Under this program, the EGA offers to develop local production facilities in poor countries to increase their access to essential medicines through local production. The project in Afghanistan was developed in close cooperation with the Business Humanitarian Forum and the United Nations Development Program and constitutes the first concrete project of the EGA under their Access to Medicines Program. More about the Afghanistan Project Business Humanitarian Forum << Back For further information contact Emily Alvarez |
| Copyright © 2004 EGA - European Generic medicines Association • • Cascading Pop-up Menus ©Angus Turnbull |